An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Clinical trial NCT05900141 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05900141
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-29
- Primary completion
- 2028-08-24
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.